Medical management of patients with peripheral arterial disease.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Angiology

• Publication date

  2015-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 24916346
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda

  2016cited by this paper
• Consensus Document on Intermittent Claudication from the Central European Vascular Forum (C.E.V.F.)-3rd revision (2013) with the sharing of the Mediterranean League of Angiology and Vascular Surgery, and the North Africa and Middle East Chapter of International Union of Angiology.

  2014cited by this paper
• Lower Limb Peripheral Arterial Disease (Clinical Guideline 147): A Guideline Summary

  2013cited by this paper
• Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.

  2013cited by this paper
• Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial.

  2013cited by this paper
• Is aspirin still the drug of choice for management of patients with peripheral arterial disease?

  2013cited by this paper
• ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

  2013cited by this paper
• Peripheral Arterial Disease

  2013cited by this paper
• Naftidrofuryl for intermittent claudication.

  2012cited by this paper
• Diagnosis and management of peripheral arterial disease

  2012cited by this paper
• Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• ESC Guidelines on the Diagnosis and Treatment of Peripheral Artery Diseases

  2012cited by this paper
• Supervised Exercise Versus Primary Stenting for Claudication Resulting From Aortoiliac Peripheral Artery Disease: Six-Month Outcomes From the Claudication Exercise Versus Endoluminal Revascularization (CLEVER) Study

  2012cited by this paper
• Secondary Prevention and Mortality in Peripheral Artery Disease: National Health and Nutrition Examination Study, 1999 to 2004

  2012cited by this paper
• Availability of supervised exercise programs and the role of structured home-based exercise in peripheral arterial disease.

  2012cited by this paper
• Exercise training in intermittent claudication: Effects on antioxidant genes, inflammatory mediators and proangiogenic progenitor cells

  2012cited by this paper
• Amputation rate and mortality in elderly patients with critical limb ischemia not suitable for revascularization.

  2012cited by this paper
• Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

  2012cited by this paper
• Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication

  2012cited by this paper
• Prognostic usefulness of clinical and subclinical peripheral arterial disease in men with stable coronary heart disease.

  2012cited by this paper
• Prevalence and risk factors for cerebral infarction and carotid artery stenosis in peripheral arterial disease.

  2012cited by this paper
• LDL lowering in peripheral arterial disease:are there benefits beyond reducing cardiovascular morbidity and mortality?

  2012cited by this paper
• 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2011cited by this paper
• 2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

  2011cited by this paper
• Chapter V: Diabetic foot.

  2011cited by this paper
• Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia.

  2011cited by this paper
• Peripheral arterial disease and progression of coronary atherosclerosis.

  2011cited by this paper
• Contemporary Reviews in Cardiovascular Medicine Exercise Rehabilitation in Peripheral Artery Disease Functional Impact and Mechanisms of Benefits

  2011cited by this paper
• Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

  2011cited by this paper
• Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

  2011cited by this paper
• Chapter IV: Treatment of critical limb ischaemia.

  2011cited by this paper
• Secondary Prevention and Mortality in Peripheral Artery Disease: National Health and Nutrition Examination Study, 1999 to 2004

  2011cited by this paper
• Screening for cardiovascular risk in asymptomatic patients.

  2010cited by this paper
• Duplex ultrasound scanning of peripheral arterial disease of the lower limb.

  2010cited by this paper
• The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration.

  2010cited by this paper
• 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2010cited by this paper
• Peripheral arterial disease in diabetes—a review

  2010cited by this paper
• Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease.

  2010cited by this paper
• Atherosclerotic plaque regression - the role of statin therapy.

  2010cited by this paper
• Peripheral Arterial Disease as an Independent Predictor for Excess Stroke Morbidity and Mortality in Primary-Care Patients: 5-Year Results of the getABI Study

  2010cited by this paper
• Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check?

  2010cited by this paper
• Exercise-based interventions and health-related quality of life in intermittent claudication: a 20-year (1989–2008) review

  2010cited by this paper
• ACCF/AHA Practice Guideline Practice Guidelines 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults

  2010cited by this paper
• Prostanoids for critical limb ischaemia.

  2010cited by this paper
• The cost-effectiveness of an extended course (12+12 weeks) of varenicline compared with other available smoking cessation strategies in the United States: an extension and update to the BENESCO model.

  2010cited by this paper
• Office management of peripheral arterial disease.

  2010cited by this paper
• Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.

  2010cited by this paper
• Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease: A Meta-analysis of Randomized Trials

  2010cited by this paper
• High prevalence of peripheral arterial disease in patients with previous cerebrovascular or coronary event

  2010cited by this paper
• Risk prediction is improved by adding markers of subclinical organ damage to SCORE.

  2010cited by this paper
• 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary

  2010cited by this paper
• Triple-combination pharmacotherapy for medically ill smokers: a randomized trial.

  2009cited by this paper
• Physical Activity During Daily Life and Functional Decline in Peripheral Arterial Disease

  2009cited by this paper
• Extended-release niacin or ezetimibe and carotid intima-media thickness.

  2009cited by this paper
• Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.

  2009cited by this paper
• Unbalanced risk factors, could compromise the effectiveness of physical training in patients with intermittent claudication?

  2009cited by this paper
• Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

  2009cited by this paper
• Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.

  2009cited by this paper
• Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality.

  2008cited by this paper
• Effectiveness and costs of a short-course supervised training program in claudicants: proposal for a shared protocol with aerobic working load.

  2008cited by this paper
• The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program

  2008cited by this paper
• Physiological and functional impact of an unsupervised but supported exercise programme for claudicants.

  2008cited by this paper
• Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis.

  2008cited by this paper
• Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease.

  2008cited by this paper
• Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol.

  2008cited by this paper
• Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia.

  2008cited by this paper
• Consensus document on intermittent claudication from the Central European Vascular Forum 1st edition - Abano Terme (Italy) - May 2005 2nd revision - Portroz (Slovenia) September 2007.

  2008cited by this paper
• Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI).

  2008cited by this paper
• Angiography: Principles, Techniques (Including CTA and MRA) and Complications

  2008cited by this paper
• Peripheral atherosclerosis is associated with the occurrence of restenosis after percutaneous coronary intervention

  2007cited by this paper
• Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions.

  2007cited by this paper
• Acute impairment of the endothelial function by maximal treadmill exercise in patients with intermittent claudication, and its improvement after supervised physical training.

  2007cited by this paper
• Cilostazol for peripheral arterial disease.

  2007cited by this paper
• Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

  2007cited by this paper
• Intermittent pneumatic compression (IPC) in the treatment of peripheral arterial occlusive disease (PAOD)--A useful tool or just another device?

  2007cited by this paper
• Circulating levels of cytokines (IL-6 and IL-1beta) in patients with intermittent claudication, at rest, after maximal exercise treadmill test and during restore phase. Could they be progression markers of the disease?

  2007cited by this paper
• ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography

  2006cited by this paper
• Physical Performance in Peripheral Arterial Disease: A Slower Rate of Decline in Patients Who Walk More

  2006cited by this paper
• Revisiting Rose: strategies for reducing coronary heart disease

  2006cited by this paper
• ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Intervent

  2006cited by this paper
• Carotid and peripheral atherosclerosis in patients who underwent primary percutaneous coronary intervention and outcome associated with multifocal atherosclerosis.

  2006cited by this paper
• The effect of exercise intensity on the response to exercise rehabilitation in patients with intermittent claudication.

  2005cited by this paper
• Excimer laser assisted angioplasty for critical limb ischemia: results of the LACI Belgium Study.

  2005cited by this paper
• Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.

  2005cited by this paper
• Beneficial Cardiovascular Pleiotropic Effects of Statins

  2004cited by this paper
• High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study.

  2004cited by this paper
• Percutaneous Peripheral Atherectomy of Femoropopliteal Stenoses Using a New-Generation Device: Six-Month Results from a Single-Center Experience

  2004cited by this paper
• Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus

  2004cited by this paper
• Applying the grades of recommendation for antithrombotic and thrombolytic therapy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Critical limb ischemia: definition and natural history.

  2004cited by this paper
• Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999–2000

  2004cited by this paper
• Statin Use and Leg Functioning in Patients With and Without Lower-Extremity Peripheral Arterial Disease

  2003cited by this paper
• High circulating levels of cytokines (IL-6 and TNFa), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test

  2003cited by this paper
• Response to exercise rehabilitation in smoking and nonsmoking patients with intermittent claudication.

  2003cited by this paper
• Peripheral Arterial Disease in People With Diabetes

  2003cited by this paper
• Acute Lower Limb Ischemia: The Value of Duplex Ultrasound Arterial Mapping (DUAM) as the Sole Preoperative Imaging Technique

  2003cited by this paper
• Classification, epidemiology, risk factors, and natural history of peripheral arterial disease

  2002cited by this paper
• Exercise training for claudication.

  2002cited by this paper

• Use of statins in patients with peripheral artery disease.

  2020cites this paper
• Cardiovascular Risk Evaluation in Patients with Critical Leg Ischemia before Vascular Surgery

  2018cites this paper
• [Antiplatelet thromboprophylaxis of arterial vascular diseases and organovascular ischemic diseases].

  2018cites this paper
• Patient-specific flow descriptors and normalised wall index in peripheral artery disease: a preliminary study

  2018cites this paper
• Simvastatin augments revascularization and reperfusion in a murine model of hind limb ischemia - Multimodal imaging assessment.

  2017cites this paper
• Effects of foot complications in patients with Type 2 diabetes mellitus on public healthcare: An analysis based on the Korea National Diabetes Program Cohort.

  2017cites this paper
• Clinical risk factors for loss of stent primary patency in patients with chronic legs ischemia.

  2017cites this paper
• Pancreatic duct stones: A report on 16 cases.

  2017cites this paper
• Patterns and determinants of use of pharmacological therapies for intermittent claudication in PAD outpatients: results of the IDOMENEO study.

  2017cites this paper
• Sustained Elevation in MonocyteLevels in Diabetic Patients after Infra-Inguinal Revascularization

  2016cites this paper
• Characteristics of patients who underwent lower limb amputation due to critical limb ischemia – one center experience

  2016cites this paper
• Atherosclerosis risk factors in male patients qualified for percutaneous stenting of lower extremity arteries. A retrospective cohort study

  2016cites this paper
• Risk factors for major leg amputation in patients treated endovascularly due to critical limb ischaemia

  2016cites this paper
• Coagulation testing in atherosclerosis and liver disease

  2016cites this paper
• Normal platelet activation profile in patients with peripheral arterial disease on aspirin.

  2015cites this paper
• The Role of Vascular Surgeon in Promoting Vascular Health and Prevention of Cardiovascular Events.

  2015cites this paper
• Statins and peripheral arterial disease.

  2015cites this paper
• Endovascular Versus Medical Therapy for Atherosclerotic Renovascular Disease

  2014cites this paper